High affinity fully human monoclonal antibodies to interleukin-8

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8604174
APP PUB NO 20090130110A1
SERIAL NO

11911940

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present embodiments are related to high-affinity antibodies directed to IL-8, methods of making and characterizing such antibodies and uses of such antibodies. Isolated polynucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR's) and/or complementarity determining regions (CDR's), are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMGEN FREMONT INC6701 KAISER DRIVE FREMONT CA 94555

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Babcook, John Vancouver, CA 20 580
Foord, Orit Foster City, US 95 1360
Kang, Jaspal S Surrey, CA 17 581
Rathanaswami, Palaniswami Vancouver, CA 18 515

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00